5 research outputs found
Pd-Catalyzed Cyanation of a Bromoaryl Carboxylate En Route to Etrumadenant: Robust Process with Low Catalyst Loading Enabled by Preactivation
Palladium-catalyzed cyanation of aryl bromides is a powerful
approach
to install a functional group commonly found in active pharmaceutical
ingredients starting from readily available precursors. The development
of a robust cyanation of a bromo benzoic acid to generate an intermediate
en route to etrumadenant is described. Full conversion with catalyst
loading as low as 0.13 mol % was enabled by study of the catalyst
preactivation step, which was affected by trace water levels. Details
of the scale-up of this process to the hundred-kilogram batch size
are included
Ullmann Diaryl Ether Synthesis: Rate Acceleration by 2,2,6,6-Tetramethylheptane-3,5-dione
Asymmetric Synthesis of Letermovir Using a Novel Phase-Transfer-Catalyzed Aza-Michael Reaction
The development of
a concise asymmetric synthesis of the antiviral
development candidate letermovir is reported, proceeding in >60%
yield
over a total of seven steps from commercially available materials.
Key to the effectiveness of this process is a novel cinchonidine-based
PTC-catalyzed aza-Michael reaction to configure the single stereocenter
Synthesis of Bis-Macrocyclic HCV Protease Inhibitor MK-6325 via Intramolecular <i>sp</i><sup>2</sup>–<i>sp</i><sup>3</sup> Suzuki–Miyaura Coupling and Ring Closing Metathesis
A practical
asymmetric synthesis of the complex fused bis-macrocyclic
HCV protease inhibitor MK-6325 (<b>1</b>) is described. Through
the combination of a high yielding and low catalyst loading ring-closing
metathesis (RCM) to forge the 15-membered macrocycle with an intramolecular <i>sp</i><sup>2</sup>–<i>sp</i><sup>3</sup> Suzuki–Miyaura
cross-coupling to append the 18-membered macrocycle, multikilogram
access to the unique and challenging architecture of MK-6325 (<b>1</b>) has been achieved
Development of an Efficient Route to 2-Ethynylglycerol for the Synthesis of Islatravir
The unnatural, alkyne-containing nucleoside analog islatravir
(MK-8591) is synthetically accessed through a biocatalytic cascade starting from
2-ethynylglycerol as a building block. Herein, we describe the development of an
efficient synthesis of this building block including the initial route, route
scouting and final process development. Key challenges that have been overcome are
the development of an efficient and safe acetylenic nucleophile addition to an appropriate
ketone, and the identification of a 2-ethynylpropane-1,2,3-triol derivative
with favorable physical properties. An acid-catalyzed cracking of commercially
available 1,3-dihydroxyacetone dimer and subsequent 1,2-addition of an
acetylenic nucleophile has been discovered and optimized into the manufacturing
proces